Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raghavan Varadarajan

Showing results (111-120 of 145) with videos related to

Pageof 15
Sort By:
NPJ Vaccines|December 22, 2017
Protective efficacy of influenza group 2 hemagglutinin stem-fragment immunogen vaccinesTroy C Sutton, Saborni Chakraborty, Vamsee V A Mallajosyula, et al.
Pharmaceutics|December 23, 2023
Enhancing Immunogenicity of a Thermostable, Efficacious SARS-CoV-2 Vaccine Formulation through Oligomerization and Adjuvant ChoiceMohammad Suhail Khan, Virginie Jakob, Randhir Singh, et al.
The Journal of Biological Chemistry|February 23, 2013
Design of an Escherichia coli expressed HIV-1 gp120 fragment immunogen that binds to b12 and induces broad and potent neutralizing antibodiesSanchari Bhattacharyya, Pranveer Singh, Ujjwal Rathore, et al.
Vaccine|September 18, 2018
Design, display and immunogenicity of HIV1 gp120 fragment immunogens on virus-like particlesMansi Purwar, Jonathan K Pokorski, Pranveer Singh, et al.
Scientific Reports|March 8, 2016
Stalking influenza by vaccination with pre-fusion headless HA mini-stemSophie A Valkenburg, V Vamsee Aditya Mallajosyula, Olive T W Li, et al.
Viruses|February 28, 2023
Neutralizing Efficacy of Encapsulin Nanoparticles against SARS-CoV2 Variants of ConcernSara Khaleeq, Nayanika Sengupta, Sahil Kumar, et al.
Frontiers in Immunology|June 20, 2022
Comparative Immunogenicity of Bacterially Expressed Soluble Trimers and Nanoparticle Displayed Influenza Hemagglutinin Stem ImmunogensUddipan Kar, Sara Khaleeq, Priyanka Garg, et al.
Frontiers in Molecular Biosciences|October 24, 2022
Combining cysteine scanning with chemical labeling to map protein-protein interactions and infer bound structure in an intrinsically disordered regionShahbaz Ahmed, Gopinath Chattopadhyay, Kavyashree Manjunath, et al.
RSC Advances|May 7, 2025
Cryo-EM reveals conformational variability in the SARS-CoV-2 spike protein RBD induced by two broadly neutralizing monoclonal antibodiesClayton Fernando Rencilin, Arnab Chatterjee, Mohammad Yousuf Ansari, et al.
Journal of Virology|March 26, 2025
Early 2022 breakthrough infection sera from India target the conserved cryptic class 5 epitope to counteract immune escape by SARS-CoV-2 variantsIndrani Das Jana, Kawkab Kanjo, Subhanita Roy, et al.
Pageof 15

Showing results (111-120 of 145) with videos related to

Sort By:
Pageof 15
NPJ Vaccines|December 22, 2017
Protective efficacy of influenza group 2 hemagglutinin stem-fragment immunogen vaccinesTroy C Sutton, Saborni Chakraborty, Vamsee V A Mallajosyula, et al.
Pharmaceutics|December 23, 2023
Enhancing Immunogenicity of a Thermostable, Efficacious SARS-CoV-2 Vaccine Formulation through Oligomerization and Adjuvant ChoiceMohammad Suhail Khan, Virginie Jakob, Randhir Singh, et al.
The Journal of Biological Chemistry|February 23, 2013
Design of an Escherichia coli expressed HIV-1 gp120 fragment immunogen that binds to b12 and induces broad and potent neutralizing antibodiesSanchari Bhattacharyya, Pranveer Singh, Ujjwal Rathore, et al.
Vaccine|September 18, 2018
Design, display and immunogenicity of HIV1 gp120 fragment immunogens on virus-like particlesMansi Purwar, Jonathan K Pokorski, Pranveer Singh, et al.
Scientific Reports|March 8, 2016
Stalking influenza by vaccination with pre-fusion headless HA mini-stemSophie A Valkenburg, V Vamsee Aditya Mallajosyula, Olive T W Li, et al.
Viruses|February 28, 2023
Neutralizing Efficacy of Encapsulin Nanoparticles against SARS-CoV2 Variants of ConcernSara Khaleeq, Nayanika Sengupta, Sahil Kumar, et al.
Frontiers in Immunology|June 20, 2022
Comparative Immunogenicity of Bacterially Expressed Soluble Trimers and Nanoparticle Displayed Influenza Hemagglutinin Stem ImmunogensUddipan Kar, Sara Khaleeq, Priyanka Garg, et al.
Frontiers in Molecular Biosciences|October 24, 2022
Combining cysteine scanning with chemical labeling to map protein-protein interactions and infer bound structure in an intrinsically disordered regionShahbaz Ahmed, Gopinath Chattopadhyay, Kavyashree Manjunath, et al.
RSC Advances|May 7, 2025
Cryo-EM reveals conformational variability in the SARS-CoV-2 spike protein RBD induced by two broadly neutralizing monoclonal antibodiesClayton Fernando Rencilin, Arnab Chatterjee, Mohammad Yousuf Ansari, et al.
Journal of Virology|March 26, 2025
Early 2022 breakthrough infection sera from India target the conserved cryptic class 5 epitope to counteract immune escape by SARS-CoV-2 variantsIndrani Das Jana, Kawkab Kanjo, Subhanita Roy, et al.
Pageof 15